These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35514164)
1. Phosphorus containing analogues of SAHA as inhibitors of HDACs. Pun MD; Wu HH; Olatunji FP; Kesic BN; Peters JW; Berkman CE J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1315-1319. PubMed ID: 35514164 [TBL] [Abstract][Full Text] [Related]
2. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity. Negmeldin AT; Knoff JR; Pflum MKH Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330 [TBL] [Abstract][Full Text] [Related]
3. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity. Negmeldin AT; Pflum MKH Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461 [TBL] [Abstract][Full Text] [Related]
4. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid. Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198 [TBL] [Abstract][Full Text] [Related]
5. The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity. Choi SE; Weerasinghe SV; Pflum MK Bioorg Med Chem Lett; 2011 Oct; 21(20):6139-42. PubMed ID: 21889343 [TBL] [Abstract][Full Text] [Related]
6. The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs. Geurs S; Clarisse D; De Bosscher K; D'hooghe M J Med Chem; 2023 Jun; 66(12):7698-7729. PubMed ID: 37276138 [TBL] [Abstract][Full Text] [Related]
7. Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and Induce Apoptosis in Breast Cancer Cells. Moku G; Vangala S; Yakati V; Gali CC; Saha S; Madamsetty VS; Vyas A Anticancer Agents Med Chem; 2022; 22(5):914-925. PubMed ID: 34488592 [TBL] [Abstract][Full Text] [Related]
8. Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents. Oanh DT; Hai HV; Park SH; Kim HJ; Han BW; Kim HS; Hong JT; Han SB; Hue VT; Nam NH Bioorg Med Chem Lett; 2011 Dec; 21(24):7509-12. PubMed ID: 22036991 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors. Huang WJ; Chen CC; Chao SW; Yu CC; Yang CY; Guh JH; Lin YC; Kuo CI; Yang P; Chang CI Eur J Med Chem; 2011 Sep; 46(9):4042-9. PubMed ID: 21712146 [TBL] [Abstract][Full Text] [Related]
10. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. Desai D; Salli U; Vrana KE; Amin S Bioorg Med Chem Lett; 2010 Mar; 20(6):2044-7. PubMed ID: 20167479 [TBL] [Abstract][Full Text] [Related]
11. SAHA Capture Compound--a novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders. Fischer JJ; Michaelis S; Schrey AK; Diehl A; Graebner OY; Ungewiss J; Horzowski S; Glinski M; Kroll F; Dreger M; Koester H Proteomics; 2011 Oct; 11(20):4096-104. PubMed ID: 21898820 [TBL] [Abstract][Full Text] [Related]
12. A cyclodextrin-capped histone deacetylase inhibitor. Amin J; Puglisi A; Clarke J; Milton J; Wang M; Paranal RM; Bradner JE; Spencer J Bioorg Med Chem Lett; 2013 Jun; 23(11):3346-8. PubMed ID: 23591111 [TBL] [Abstract][Full Text] [Related]
13. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket. Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors. Zhang S; Huang W; Li X; Yang Z; Feng B Chem Biol Drug Des; 2015 Oct; 86(4):795-804. PubMed ID: 25763653 [TBL] [Abstract][Full Text] [Related]
15. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin. Jin JS; Tsao TY; Sun PC; Yu CP; Tzao C Pathol Oncol Res; 2012 Jul; 18(3):713-20. PubMed ID: 22270866 [TBL] [Abstract][Full Text] [Related]
16. Coumarin-suberoylanilide hydroxamic acid as a fluorescent probe for determining binding affinities and off-rates of histone deacetylase inhibitors. Singh RK; Mandal T; Balasubramanian N; Cook G; Srivastava DK Anal Biochem; 2011 Jan; 408(2):309-15. PubMed ID: 20816742 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors. Zhang Y; Feng J; Liu C; Fang H; Xu W Bioorg Med Chem; 2011 Aug; 19(15):4437-44. PubMed ID: 21733698 [TBL] [Abstract][Full Text] [Related]